2-(Tetrahydro-1H-pyrrolizin-7a(5H)-yl)ethan-1-amine bis(2,2,2-trifluoroacetate)

Catalog No.: 
ACZLRF165
CAS No.: 
2173091-82-0
Molecular Formula: 
C13H20F6N2O4
Molecular Weight: 
382.30
2-(Tetrahydro-1H-pyrrolizin-7a(5H)-yl)ethan-1-amine bis(2,2,2-trifluoroacetate) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$108.00InquiryInquiry
250mg95%$197.00InquiryInquiry
1g95%$772.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Tetrahydro-1H-pyrrolizin-7a(5H)-yl)ethan-1-amine bis(2,2,2-trifluoroacetate)
IUPAC Name2-(tetrahydro-1H-pyrrolizin-7a(5H)-yl)ethan-1-amine bis(2,2,2-trifluoroacetate)
Molecular FormulaC13H20F6N2O4
Molecular Weight382.30
SMILESNCCC12CCCN1CCC2.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
InChI KeyREUXZEIBZAFHSF-UHFFFAOYSA-N
Synonym2-(hexahydro-1H-pyrrolizin-7a-yl)ethan-1-amine ditrifluoroacete;2-(tetrahydro-1h-pyrrolizin-7a(5h)-yl)ethan-1-amine bis(2,2,2-trifluoroacetate)
CAS No.2173091-82-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACZLRF165 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCPTM128 route compound structure diagram
    ACCPTM12878449-75-9In Stock
  2. Then
  3. ACZLRF165 route product structure diagram
    ACZLRF1652173091-82-0
Inquiry

2. ACZLRF165 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZLRF165 route product structure diagram
    ACZLRF1652173091-82-0
Inquiry

3. ACZLRF165 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZLRF165 route product structure diagram
    ACZLRF1652173091-82-0
Inquiry

Comments (0)